Filing Details
NKGen Biotech, Inc. (NYSE:GFOR) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedNYSE:GFOR
NKGen Biotech, Inc. (GFOR) Reports Material Event to SEC
Filing Details NKGen Biotech, Inc. (NYSE:GFOR) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context NKGen…
Market Context
NKGen Biotech, Inc.'s stock currently trades at $8.30 with a market capitalization of $86.1M. The Financial Services company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for NKGen Biotech, Inc.'s stock.
All SEC filings for NKGen Biotech, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GFOR Stock Page
Frequently Asked Questions
Where can I read GFOR's SEC filings?
Browse all filings on our GFOR SEC filings page.
What types of SEC filings does NKGen Biotech, Inc. file?
Public companies like NKGen Biotech, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.